Healthcare research multiple myeloma: latencies to diagnosis and treatment

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00008551

Enrollment

100

Registered

2015-05-13

Start date

2015-02-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C90.0

Interventions

Group 1: There is a lack of literature on the issue of how much time is needed between the incidence of symptoms to definitive diagnosis in patients with MM. In particular, non-specific symptoms, such

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with multiple myeloma

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The aim is to detect if multiple myeloma patients have optimal framework in healthcare. Therefore a early diagnose und introduction of therapy are necessary to get the best possible treatment outcome.	—

Countries

Germany

Contacts

Public ContactMonika Engelhardt Engelhardt

Uniklinik Freiburg

monika.engelhardt@uniklinik-freiburg.de+49 761 270 32460

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026